tirzepatide

What Is Tirzepatide?

You may have heard of the popular GLP-1 medication Semaglutide, which has been making a name for itself in the medical weight loss industry. Tirzepatide, also commonly referred to by the brand name Mounjaro, is somewhat similar – but even more powerful.

In studies recently submitted to the FDA by Lilly, Tirzepatide (which is already approved for treating Type 2 diabetes) was shown to lower body mass among users at its highest dose by up to 15%.

While Semaglutide targets the molecule glucagon-like peptide-1 (GLP-1) that’s involved in insulin secretion, tirzepatide is the first to target two: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP).